Data on Phase 2 Dep Docetaxel and Dep Cabazitaxel human trials
Completion of recruitment and treatment of Viraleze™ human trial
Share price appreciation to reflect the above
Announcement of replacement for CEO
Announcement of retirement of Chairman
Hopefully new submission to FDA for NDA of Vivagel
Announcement of new partners for distribution of Vivagel_b with substantial up front licensing fees
- Forums
- ASX - By Stock
- Expectations for September
SPL
starpharma holdings limited
Add to My Watchlist
1.08%
!
9.4¢

Data on Phase 2 Dep Docetaxel and Dep Cabazitaxel human trials...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $39.31M |
Open | High | Low | Value | Volume |
9.3¢ | 9.5¢ | 9.3¢ | $23.49K | 249.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.094 |
1 | 5500 | 0.093 |
1 | 100000 | 0.092 |
1 | 100000 | 0.091 |
2 | 350000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 50000 | 1 |
0.099 | 287150 | 11 |
0.100 | 21000 | 3 |
0.105 | 170000 | 3 |
0.110 | 14280 | 1 |
Last trade - 15.42pm 08/07/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |